ETF · Nasdaq: BIB
BIB — ProShares Ultra Nasdaq Biotechnology
ProShares Ultra Nasdaq Biotechnology (BIB) is an exchange-traded fund listed on Nasdaq. On Bright Analyst you can analyze BIB's holdings, sector allocation, performance, expense ratio, dividends and similar ETFs, alongside an AI-written fund analysis.
Key facts
- Ticker symbol
- BIB
- Exchange
- Nasdaq
- ISIN
- US74347R2141
- Security type
- Exchange-traded fund
Research BIB
- Price Chart — Interactive price history with AI commentary.
- Fund Analysis — Fund profile, strategy, index and an AI-written analysis.
- Performance — Returns, valuation and expense ratio against its category.
- Holdings — Every position with its weight, sector and asset type.
- Allocation — Sector, asset-class and top-holding concentration.
- Peers — Comparison with similar ETFs on cost, returns and holdings.
- Dividends — Dividend yield and distribution history.
- News — Latest headlines about the fund and its issuer.
Frequently asked questions
What is the BIB ETF?
BIB is the ticker symbol of ProShares Ultra Nasdaq Biotechnology, an exchange-traded fund listed on Nasdaq with ISIN US74347R2141.
What does BIB hold?
The BIB Holdings page lists every position in ProShares Ultra Nasdaq Biotechnology with its portfolio weight, and the Allocation page breaks the fund down by sector and asset class.
Does BIB pay a dividend?
The BIB Dividends page shows the fund's dividend yield and distribution history for any period in which it has paid distributions.
What are alternatives to BIB?
The BIB Peers page compares ProShares Ultra Nasdaq Biotechnology with similar ETFs on cost, performance and holdings.
For information only — not investment advice.